Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ReneGait is a medical technology company specializing in the development of wearable devices for gait rehabilitation. The company's primary product is a non-invasive wearable designed to assist individuals with "drop foot," a condition often resulting from stroke or multiple sclerosis. By providing real-time sensory feedback, the device helps users improve their walking pattern, speed, and overall mobility. ReneGait originated as a spin-out from the University of Strathclyde and focuses on enhancing the quality of life for patients with neurological impairments through innovative biomechanical solutions. The technology is designed for use both in clinical settings and for home-based rehabilitation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ReneGait.